Navigation Links
NJIT author to speak at UNC about hemophilia
Date:3/26/2012

NJIT Associate Professor Stephen Pemberton has been invited to speak at the Bullitt History of Medicine Club at the University of North Carolina (UNC) about how hemophilia became manageable in the 20th century. Pemberton is the author of The Bleeding Disease: Hemophilia and the Unintended Consequences of Medical Progress (Johns Hopkins University Press, 2011). He is also an expert on hemophilia and the medical developments of the 20th-century that transformed the illness from an obscure hereditary malady into a manageable bleeding disorder. He teaches in the Federated Dept. of History at NJIT and Rutgers-Newark.

The talk, set for tomorrow at 5:30 p.m. in the UNC Health Science Library (Room 527), is free and open to the public. To attend, call 919-962-0500 or visit the Bullitt History of Medicine Club, http://www.med.unc.edu/bhomc/.

Pemberton's lecture will focus on pioneering medicine at UNC and highlight early research into hemophilia there. Eventually this work led to the establishment of the UNC Hemophilia and Thrombosis Center, recognized by the World Federation of Hemophilia as an International Hemophilia Training Center. In addition to Pemberton's continued research on the problems associated with the historical management of chronic diseases, he is investigating the role of hematologists in the development of modem genetic medicine. He is interested in the cultural, social and health implications of blood as a commodity.

Pemberton was co-recipient of the 2006 Association of American Publishers/Professional and Scholarly Publishing Division book award in the history of science category. He received an M.A. in Philosophy from the University of Memphis and an M.A. & Ph.D. in the History of Science University of North Carolina at Chapel Hill.


'/>"/>

Contact: Sheryl Weinstein
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Page: 1

Related medicine news :

1. Aging authorities differ on tweaks to Social Securitys benefit structure
2. Academics guest authoring ghostwritten medical journal articles should be charged with fraud
3. UDs Roberta Colman ranks in top 50 most prolific authors in Biochemistry
4. Controversial TOFT theory of cancer versus SMT model: Authors do battle in BioEssays
5. OHSU expert co-authors study finding treatment for rare lung disease
6. Boston University School of Medicine professor co-authors first book on deaf ethnicity
7. Women and Infants physician authors chapter in reference book
8. Author who revealed unethical Guatemala syphilis study writes for Bioethics Forum
9. Medical Study Authors Often Fail to Disclose Industry Ties
10. UNC physician authors editorial on cost-effectiveness study for colon cancer screening
11. Self-Published Author Shares Her Personal Story of Hope Amidst Despair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: